Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Synflorix Primary Vaccination in African Infants
NCT00678301Phase 3Completed
- Sponsor
- GSK
- Start
- Jun 2008
- Primary completion
- Nov 2009
- Modality
- Split/Subunit Vaccines
- Countries
- 2
01
Overview
A Phase 3 trial of 10-valent pneumococcal conjugate vaccine in pneumococcal infection, sponsored by GSK. Started Jun 2008; status: completed.
02
Drugs
10-valent pneumococcal conjugate vaccine
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT00678301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00678301.